91 related articles for article (PubMed ID: 24152617)
1. SPECT and 18F-FDG PET/CT imaging of multiple paragangliomas and a growth hormone-producing pituitary adenoma as phenotypes from a novel succinate dehydrogenase subunit D mutation.
Skoura E; Datseris IE; Xekouki P; Tolis G; Stratakis CA
Clin Nucl Med; 2014 Jan; 39(1):81-3. PubMed ID: 24152617
[TBL] [Abstract][Full Text] [Related]
2. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
[TBL] [Abstract][Full Text] [Related]
3. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
[TBL] [Abstract][Full Text] [Related]
4. Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions.
Kornaczewski ER; Pointon OP; Burgess JR
Clin Endocrinol (Oxf); 2016 Aug; 85(2):172-9. PubMed ID: 26776272
[TBL] [Abstract][Full Text] [Related]
5. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
Marzola MC; Chondrogiannis S; Grassetto G; Rampin L; Maffione AM; Ferretti A; Opocher G; Schiavi F; Colletti PM; Rubello D
Clin Nucl Med; 2014 Jan; 39(1):e53-8. PubMed ID: 23856824
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
Clin Nucl Med; 2015 May; 40(5):439-41. PubMed ID: 25742231
[TBL] [Abstract][Full Text] [Related]
7. Unusual case of Cowden-like syndrome, neck paraganglioma, and pituitary adenoma.
Efstathiadou ZA; Sapranidis M; Anagnostis P; Kita MD
Head Neck; 2014 Jan; 36(1):E12-6. PubMed ID: 23804288
[TBL] [Abstract][Full Text] [Related]
8. 68Ga DOTATATE PET/CT in a rare coexistence of pituitary macroadenoma and multiple paragangliomas.
Parghane RV; Agrawal K; Mittal BR; Shukla J; Bhattacharya A; Mukherjee KK
Clin Nucl Med; 2014 Jan; 39(1):91-3. PubMed ID: 24152628
[TBL] [Abstract][Full Text] [Related]
9. Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report.
Papaspyrou K; Rossmann H; Fottner C; Weber MM; Mann W; Lackner KJ; Helling K
Head Neck; 2008 Jul; 30(7):964-9. PubMed ID: 18213727
[TBL] [Abstract][Full Text] [Related]
10. Succinate dehydrogenase mutation-related paragangliomas: conventional versus PET/CT diagnostic work-up.
Marzola MC; Chondrogiannis S; Colletti PM; Rubello D
Nucl Med Commun; 2015 Jul; 36(7):657-65. PubMed ID: 25734542
[No Abstract] [Full Text] [Related]
11. Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT imaging in a case of pituitary metastases.
Hou Y; Zhu Z; Jin X; Wang R; Xing B
Clin Nucl Med; 2013 Jul; 38(7):550-2. PubMed ID: 23657139
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
13. Metastatic pheochromocytoma and paraganglioma.
Angelousi A; Kassi E; Zografos G; Kaltsas G
Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
[TBL] [Abstract][Full Text] [Related]
14. Extensive hypermetabolic pattern of brown adipose tissue activation on 18F-FDG PET/CT in a patient diagnosed of catecholamine-secreting para-vesical paraganglioma.
Banzo J; Ubieto MA; Berisa MF; Andrés A; Mateo ML; Tardín L; Parra A; Razola P; Prats E
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):397-9. PubMed ID: 23867638
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?
Xekouki P; Pacak K; Almeida M; Wassif CA; Rustin P; Nesterova M; de la Luz Sierra M; Matro J; Ball E; Azevedo M; Horvath A; Lyssikatos C; Quezado M; Patronas N; Ferrando B; Pasini B; Lytras A; Tolis G; Stratakis CA
J Clin Endocrinol Metab; 2012 Mar; 97(3):E357-66. PubMed ID: 22170724
[TBL] [Abstract][Full Text] [Related]
16. Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [
Ohtake M; Tateishi K; Murata H; Nagashima Y; Yamanaka S; Yamamoto T
World Neurosurg; 2018 Jun; 114():47-52. PubMed ID: 29510284
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract][Full Text] [Related]
18. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
Thambugala GM; Fulham MJ; Mohamed A
Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
Taïeb D; Sebag F; Barlier A; Tessonnier L; Palazzo FF; Morange I; Niccoli-Sire P; Fakhry N; De Micco C; Cammilleri S; Enjalbert A; Henry JF; Mundler O
J Nucl Med; 2009 May; 50(5):711-7. PubMed ID: 19372492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
